Pharmaceuticals

J&J may buy Synthes in $20-bn deal

16 Apr 2011

Dr. Reddy’s launch generic Fexofenadine HCl antihistamine tablets

14 Apr 2011

GlaxoSmithKline loses appeal in Rs71.21-crore Drug Price Equalisation Account demand

13 Apr 2011

Government mulls restictions on unrestricted use of antibiotics

13 Apr 2011

The government is considering colour coding of third-generation antibiotics and limiting access to such drugs strictly to tertiary hospitals to prevent their non-therapeutic consumption

GW Pharma, Novartis sign deal to market cannabis derivative

12 Apr 2011

Merck, Sun Pharma in generics JV

11 Apr 2011

The joint venture will develop and commercialise novel formulations and combinations of medicines in emerging markets

Sinclair Pharma and IS Pharma agree to terms of a £130 million merger

08 Apr 2011

Indian drug-maker stops sales of 'lethal injection' drug to US

08 Apr 2011

International human rights and anti-capital punishment campaigners have been urging the Mumbai-based pharma firm to stop selling the drug to US states that used it to execute death-row prisoners

New drug resistant bugs worry health experts

08 Apr 2011

CCEA clears Reckitt Benckiser's Rs3,300-cr Paras Pharma acquisition

29 Mar 2011

Reckitt Benckiser plc will set up a new wholly owned subsidiary investing company to acquire the entire stake in Paras Pharmaceuticals.

AstraZeneca saves over $1 billion in tax dispute settlement

28 Mar 2011

Quest Diagnostics to acquire Celera Corp for $671 million

19 Mar 2011

Teva to issue $750 million of bonds at Libor +0.50 per cent

17 Mar 2011

Regulator hikes prices of domestic insulin, TB drugs

17 Mar 2011

Eli Lilly to acquire Johnson & Johnson’s animal health unit

15 Mar 2011

Mount Kellet, others to buy 35 per cent stake in MedPlus

14 Mar 2011

HC nod for winding up Wockhardt; company to appeal

12 Mar 2011

Merck hopes to be among top-five drugmakers in India

11 Mar 2011

US drug major Merck is looking at catching up with its rivals including Glaxo Smith-Kleing (GSK) and Abbott to be among the top five players in India

Licences for 11 drug formulations withdrawn

09 Mar 2011

Dr Reddy’s targets $1 bn revenue from generics

07 Mar 2011

The Hyderabad-based company, a leader in genetic drugs, sold $600 million worth of generics globally in the nine months of this fiscal ended 31 December

Strides gets US FDA nod to market `Vancomycin' from new facility

04 Mar 2011

Panacea Biotec in marketing deal with Uruguay's Laboratorios Clausen

03 Mar 2011

Daiichi Sankyo acquires US cancer drug firm Plexxikon

02 Mar 2011

Forest Laboratories to acquire Clinical Data for $1.2 billion

23 Feb 2011

The acquisition will allow Forest to leverage its existing presence in the anti-depressant category through the launch of Viibryd.

Japanese pharma firm KHK to buy Scotland’s ProStrakan for £292 million

22 Feb 2011